Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A transgenic zebrafish model for the in vivo study of the blood and choroid plexus brain barriers using claudin 5.

van Leeuwen LM, Evans RJ, Jim KK, Verboom T, Fang X, Bojarczuk A, Malicki J, Johnston SA, van der Sar AM.

Biol Open. 2018 Feb 2;7(2). pii: bio030494. doi: 10.1242/bio.030494.

2.

A fluorescence-based reporter for monitoring expression of mycobacterial cytochrome bd in response to antibacterials and during infection.

Boot M, Jim KK, Liu T, Commandeur S, Lu P, Verboom T, Lill H, Bitter W, Bald D.

Sci Rep. 2017 Sep 6;7(1):10665. doi: 10.1038/s41598-017-10944-4.

3.

Inorganic Phosphate Limitation Modulates Capsular Polysaccharide Composition in Mycobacteria.

van de Weerd R, Boot M, Maaskant J, Sparrius M, Verboom T, van Leeuwen LM, Burggraaf MJ, Paauw NJ, Dainese E, Manganelli R, Bitter W, Appelmelk BJ, Geurtsen J.

J Biol Chem. 2016 May 27;291(22):11787-99. doi: 10.1074/jbc.M116.722454. Epub 2016 Apr 4.

4.

Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.

Abdallah AM, Hill-Cawthorne GA, Otto TD, Coll F, Guerra-Assunção JA, Gao G, Naeem R, Ansari H, Malas TB, Adroub SA, Verboom T, Ummels R, Zhang H, Panigrahi AK, McNerney R, Brosch R, Clark TG, Behr MA, Bitter W, Pain A.

Sci Rep. 2015 Oct 21;5:15443. doi: 10.1038/srep15443.

5.

Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunity.

Stoop EJ, Mishra AK, Driessen NN, van Stempvoort G, Bouchier P, Verboom T, van Leeuwen LM, Sparrius M, Raadsen SA, van Zon M, van der Wel NN, Besra GS, Geurtsen J, Bitter W, Appelmelk BJ, van der Sar AM.

Cell Microbiol. 2013 Dec;15(12):2093-108. doi: 10.1111/cmi.12175. Epub 2013 Aug 22.

6.

PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5.

Abdallah AM, Verboom T, Weerdenburg EM, Gey van Pittius NC, Mahasha PW, Jiménez C, Parra M, Cadieux N, Brennan MJ, Appelmelk BJ, Bitter W.

Mol Microbiol. 2009 Aug;73(3):329-40. doi: 10.1111/j.1365-2958.2009.06783.x. Epub 2009 Jul 7.

7.

A specific secretion system mediates PPE41 transport in pathogenic mycobacteria.

Abdallah AM, Verboom T, Hannes F, Safi M, Strong M, Eisenberg D, Musters RJ, Vandenbroucke-Grauls CM, Appelmelk BJ, Luirink J, Bitter W.

Mol Microbiol. 2006 Nov;62(3):667-79.

8.

Molecular patchwork: Chromosomal recombination between two Helicobacter pylori strains during natural colonization.

Smeets LC, Arents NL, van Zwet AA, Vandenbroucke-Grauls CM, Verboom T, Bitter W, Kusters JG.

Infect Immun. 2003 May;71(5):2907-10.

9.

Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in alpha3-fucosyltransferase genes.

Appelmelk BJ, Martin SL, Monteiro MA, Clayton CA, McColm AA, Zheng P, Verboom T, Maaskant JJ, van den Eijnden DH, Hokke CH, Perry MB, Vandenbroucke-Grauls CM, Kusters JG.

Infect Immun. 1999 Oct;67(10):5361-6. Erratum in: Infect Immun 1999 Dec;67(12):6715.

10.

Phase variation in Helicobacter pylori lipopolysaccharide.

Appelmelk BJ, Shiberu B, Trinks C, Tapsi N, Zheng PY, Verboom T, Maaskant J, Hokke CH, Schiphorst WE, Blanchard D, Simoons-Smit IM, van den Eijnden DH, Vandenbroucke-Grauls CM.

Infect Immun. 1998 Jan;66(1):70-6.

11.

Mechanisms of resistance to piperacillin of Enterobacter cloacae strains differ by antibiotic prescription policy.

Namavar F, Verboom T, van de Klundert JA, van Gestel MH, Zaal J, Maclarena DM.

Int J Antimicrob Agents. 1997;8(3):205-8.

PMID:
18611803
12.

Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide.

Simoons-Smit IM, Appelmelk BJ, Verboom T, Negrini R, Penner JL, Aspinall GO, Moran AP, Fei SF, Shi BS, Rudnica W, Savio A, de Graaff J.

J Clin Microbiol. 1996 Sep;34(9):2196-200.

13.

Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J.

Infect Immun. 1996 Jun;64(6):2031-40.

14.

In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.

Pavicić MJ, Namavar F, Verboom T, van Winkelhoff AJ, De Graaff J.

Antimicrob Agents Chemother. 1993 May;37(5):1184-6. Erratum in: Antimicrob Agents Chemother 1993 Sep;37(9):2044.

Supplemental Content

Loading ...
Support Center